Radium-223 dichloride for the treatment of metastatic prostate cancer
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656566.2014.955016
Reference30 articles.
1. Metastasis to bone: causes, consequences and therapeutic opportunities
2. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
3. Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer
4. Costs of Prostate Cancer, Metastatic to the Bone, in The Netherlands
5. Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: Data from >600 patients in the control arm of the STAMPEDE trial (NCT00268476).
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Use of Radionuclides in Bone and Joint Disease;Orthopedic Nuclear Medicine;2017
2. Radionuclides emitting short-range particles and modular nanotransporters for their delivery to target cancer cells;Russian Chemical Reviews;2016-09-30
3. Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases;Annals of Nuclear Medicine;2016-06-07
4. Therapeutic Radiopharmaceuticals for Bone Pain Palliation;Radiopharmaceuticals for Therapy;2016
5. One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer;Cancer Biotherapy and Radiopharmaceuticals;2015-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3